HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oculopharyngodistal Myopathy

Networked: 9 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1. Leukoencephalopathies
2. Muscular Diseases (Myopathy)
3. Fragile X Tremor Ataxia Syndrome
4. Neuronal intranuclear inclusion disease
5. Oculopharyngeal Muscular Dystrophy

Experts

1. Deng, Jianwen: 2 articles (01/2022 - 01/2021)
2. Hong, Daojun: 2 articles (01/2022 - 01/2021)
3. Wang, Zhaoxia: 2 articles (01/2022 - 01/2021)
4. Yu, Jiaxi: 2 articles (01/2022 - 01/2021)
5. Yuan, Yun: 2 articles (01/2022 - 01/2021)
6. Boivin, Manon: 1 article (01/2022)
7. Charlet-Berguerand, Nicolas: 1 article (01/2022)
8. Liufu, Tongling: 1 article (01/2022)
9. Zheng, Yilei: 1 article (01/2022)
10. Cao, Lanxiao: 1 article (10/2021)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Oculopharyngodistal Myopathy:
1. 5' Untranslated Regions (5' UTR)IBA
01/01/2021 - "The expansion of GGC repeat in the 5' untranslated region of the NOTCH2NLC has been associated with various neurogenerative disorders of the central nervous system and, more recently, oculopharyngodistal myopathy. "
01/01/2021 - "5' UTR CGG repeat expansion in GIPC1 is associated with oculopharyngodistal myopathy."
11/03/2023 - "Oculopharyngodistal myopathy (OPDM) is a rare adult-onset neuromuscular disease, associated with CGG repeat expansions in the 5' untranslated region of LRP12, GIPC1, NOTCH2NLC and RILPL1. "
01/01/2022 - "Recently, inspired by the similar clinical and pathological features shared with fragile X-associated tremor/ataxia syndrome (FXTAS), abnormal expansion of CGG repeats in the 5' untranslated region has been found in neuronal intranuclear inclusion disease (NIID), oculopharyngeal myopathy with leukoencephalopathy (OPML), and oculopharyngodistal myopathy (OPDMs). "
10/01/2021 - "Since then, the number of reported cases with NOTCH2NLC GGC repeat expansion in Asian and European populations has increased rapidly, indicating that the expanded mutation not only leads to the onset or progression of the NIID, but also may play an important role in multiple progressive neurological disorders, including Parkinson's disease, essential tremor, multiple system atrophy, Alzheimer's disease, frontotemporal dementia, amyotrophic lateral sclerosis, leukoencephalopathy, and oculopharyngodistal myopathy type 3. Nevertheless, the underlying pathogenic mechanism of the NOTCH2NLC 5' UTR region GGC repeat expansion in these disorders remains largely unknown. "
2. Poly(A)-Binding Protein IIIBA
3. Poly(A)-Binding Proteins (Poly(A)-Binding Protein)IBA
4. UbiquitinIBA
5. LDL Receptors (LDL Receptor)IBA
6. Proteins (Proteins, Gene)FDA Link
7. Anesthetics (Anesthetic Agents)IBA